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Abstract Metrics have become all pervasive in global health today. Instead of highlighting their
advantages or shortcomings, this article builds on Hacking’s notion of historical ontology and
explores their political, conceptual and material conditions of possibility. Drawing on research on
the Bloomberg Initiative to Reduce Tobacco Use in Developing Countries, one of the largest
international efforts to address the non-communicable disease epidemic in the global South, the
article starts by introducing the notion of epidemiological reason – a thought style associated with
modern epidemiology that undergirds the metrics permeating the global health field and which is
made of a multiplicity of elements, from the ethical imperative to save lives to the social-scientific
technique of the survey and the concept of global population. The article then goes on to explore
the genealogy of this thought style, arguing that three epistemological ruptures have been critical
to its development: the reconfiguration of power articulated around a biopolitics of population in
the eighteenth and nineteenth centuries; the twentieth-century shift in medical thought marked by
the emergence of surveillance medicine and the idea of lifestyle; and the re-organisation of world
health informed by globalisation theories at the start of the twenty-first century.
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Introduction
In the Spring of 2007, The Lancet, arguably the most influential journal in the field of global
health, published a piece entitled: ‘‘How to Prevent 100 Million Deaths from Tobacco’’. In it,
the authors – Michael Bloomberg, the billionaire entrepreneur and then Mayor of New York
City, and Tom Frieden, the City’s then Health Commissioner and now Director of the US
Centres for Diseases Control (CDC) – announced the launch of one of the first, major global
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health initiatives to tackle the growing non-communicable disease (NCD) epidemic in the
global South: the Bloomberg Initiative to Reduce Tobacco Use in Developing Countries.
Financed by the Bloomberg and Gates foundations and building on New York’s successful
anti-smoking campaign, the Initiative brings together international and American health
organisations with local government agencies and civil society groups to fight smoking in
low- and middle-income countries (Bloomberg Philanthropies, 2011). One of the Initiative’s
most striking features is how numbers and quantification practices permeate its rhetoric,
organisation and management. In their Lancet article, for example, Frieden and Bloomberg
(2007, p. 1758) justify the Initiative’s focus on tobacco by emphasising that it is ‘‘the world’s
leading agent of death’’ and will ‘‘kill one billion people prematurely during this century’’.
They also explain that the Initiative is built around a ‘‘quantifiable target’’ – a decline in
‘global adult smoking prevalence’ of ‘‘20 per cent by 2020’’ – and a ‘‘package’’ of measures
whose ‘‘effectiveness’’ has been evidenced through rigorous evaluations (ibid, pp. 1758 and
1761). Likewise, they point out to the Initiative’s ad hoc epidemiological surveillance system
that allows to ‘‘monitor results’’ and ‘‘guide programme implementation’’ (ibid, p. 1760).
This central role of numbers and quantification practices is, of course, not unique to the
Bloomberg Initiative. Indeed, it is common to the entire global health field (Adams, 2016a;
Gorsky and Sirrs, 2017; Mahajan, 2017) and part of a wider ‘‘quantificational spirit’’ that
shapes the way in which most aspects of political, economic and social life are administered
nowadays (Power, 2004, p. 766; e.g., Power, 1999; Shore and Wright, 2015) – a spirit that
will only become more prevalent in the coming years as we enter ‘‘the era of big data’’ (Boyd
and Crawford, 2012, p. 663).
Scholarly work on quantification tends to be strongly polarised and the literature on
global health metrics is no exception in that respect (Power, 2004). On one side, we have
health experts and epidemiologists who, for the most part, celebrate the enlightening power
of numbers, which they see as a product of scientific progress and the triumph of reason over
ideology and tradition. For them, metrics make health issues visible, identify effective public
health strategies and determine the most rational way to organise and manage healthcare
(e.g., Murray and Evans, 2003; Jamison et al., 2006; Lopez et al., 2006; Horton, 2013). On
the other side, there are critically minded scholars in the social sciences and humanities for
whom numbers and their association with ‘‘dangerous neoliberal arrangements’’ and ‘‘forms
of profit seeking’’ need to be denounced (Adams, 2016b, pp. 189–190). For these scholars,
metrics will always fail to convey the complexities of people’s everyday lives and foreclose
other, non-quantitative forms of politics and healthcare (e.g., Birn, 2009; Erikson, 2012;
Storeng and Behague, 2014; Adams, 2016a). In contrast to this literature and its concerns
with the benefits and limitations of quantification, the present article seeks to understand
how metrics came to dominate the field of global health in the first place. Specifically,
focusing on the Bloomberg Initiative and building on Ian Hacking’s (2002) notion of
historical ontology and his work on the history of statistical reason (Hacking, 1990, 1992;
cf. also: Porter, 1995; Desrosie`res, 1998), this article queries the conditions of possibility of
contemporary global health metrics and explores the ways in which the forms of expertise,
institutions and practices that undergird these metrics have been assembled over time. To do
so, I start by giving a brief account of the Bloomberg Initiative before introducing the notion
of epidemiological reason to capture the thought style or logic that weaves together and
shapes the metrics permeating the Initiative. I then explore the genealogy of this thought
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style and argue that three successive epistemological ruptures were critical to its articulation.
I conclude by reflecting on the insights that this genealogical approach offers to the study of
global health metrics.
The Bloomberg Initiative and Epidemiological Reason
The Bloomberg Initiative to Reduce Tobacco Use in Developing Countries was launched by
Michael Bloomberg through his charity, Bloomberg Philanthropies, in 2007 (Bloomberg
Philanthropies, 2011). One year later, he was joined by Bill and Melinda Gates, whose
foundation added another US$ 125 million to the nearly US$ 1 billion invested by
Bloomberg (Gates Foundation, 2015; Bloomberg Philanthropies, 2016). For Bloomberg and
the Gateses, the Initiative is part of their wider commitment to ‘‘make a better world’’ and
‘‘giving back’’ to the community (Bloomberg, 2001, p. 242; Gates and Gates, 2010, p. 2). As
already mentioned, the Initiative builds on the anti-smoking campaign that Health
Commissioner Tom Frieden and his team ran in New York City during Bloomberg’s
mayoralty. For Bloomberg and Frieden, who had been tasked by the Mayor with designing
the Initiative, the latter was a great opportunity to showcase their work in New York at a
time when, following the adoption of the WHO Framework Convention on Tobacco
Control (FCTC), there was growing momentum in the international fight against smoking
(Reubi and Berridge, 2016). In keeping with Frieden’s original blueprint, the Initiative is
organised around a small number of official partners: the WHO’s Tobacco Free Initiative,
the CDC, the Johns Hopkins’ School of Public Health and a few, mostly American charities
like the Campaign for Tobacco Free Kids. The mandate of these partners is to help reduce
tobacco use in the global South by building tobacco control capacity on the ground, setting
up anti-smoking coalitions, establishing epidemiological surveillance systems and supporting
local NGOs and government agencies to pass anti-smoking laws, raise tobacco taxes, run
public awareness campaigns and so on (WHO, 2013).
As outlined in the introduction, the Bloomberg Initiative is saturated with metrics. These
metrics, I suggest here, are part of a wider thought style – epidemiological reason – at work
throughout the Initiative. Broadly speaking and before examining it in more detail below, I
conceive this style of reasoning as a grid of intelligibility and action articulated around a
series of ethical values, management principles, quantification techniques and political
categories, some of which are closely related to modern epidemiology. This understanding
draws, of course, on the work of Hacking (1992, 2002) and others (e.g., Fleck, 1979; Hass,
1992; Mirowski and Plehwe, 2009). According to this more or less coherent body of work, a
thought style is similar to Michel Foucault’s episteme or discursive formation (Rose, 2000,
p. 5; Hacking, 2002, p. 180). It is a ‘‘way of seeing and practising’’ (Rose, 2000, p. 5), a ‘‘set
of epistemic commitments’’ (Mirowski and Plehwe, 2009, p. 417) that ‘‘makes possible
certain ideas and renders others unthinkable’’ (Hacking, 2002, p. 180). A style of reasoning
is often associated, though by no means coterminous, with a formalised body of knowledge
like economics, psychiatry or – as is the case here – modern epidemiology (Hacking, 1992;
Rose, 2000). This association does not mean, however, that the influence of thought styles is
constrained to the production of scientific truth. On the contrary, they often spill over and
shape political, economic and social life (Hass, 1992; Mirowski and Plehwe, 2009).
A genealogy of epidemiological reason
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At the heart of the epidemiological thought style that informs the Bloomberg Initiative is
the desire to save and improve the greatest number of human lives. This desire to save lives is
expressed repeatedly in the Initiative’s official materials. So, for example, a pamphlet
published by the Gates foundation states that:
[We] work to help all people lead healthy, productive lives … [Our tobacco control
work is about] making a difference and saving lives (Gates Foundation, 2009, p. 1).
Similarly, Michael Bloomberg, in a speech made to activists working for the Initiative,
mused that:
[The Initiative] is a great opportunity to have to a positive impact on the world…We
can take great pride in helping people and their children have better, longer and
healthier lives.
Also at the heart of epidemiological reason is the belief that efforts to save lives have to be
based on rigorous epidemiological data in order to be effective. A good illustration is the
way experts working for Bloomberg and Gates carefully analysed existing global health
statistics before deciding to focus their efforts on tobacco. Four epidemiological research and
surveillance projects, which all established that smoking was now the leading cause of death
worldwide, were especially influential in that respect: Chris Murray and Alan Lopez’ Global
Burden of Disease venture; Richard Peto’s work on global, smoking-attributable mortality;
the Tobacco Atlas project based on the American Cancer Society’s NATIONS monitoring
system; and the CDC’s Global Youth Tobacco Survey (GYTS) (e.g., Lopez et al., 2006; Peto
and Lopez, 2000; Mackay and Eriksen, 2002; Warren et al., 2009). As two public health
specialists involved in setting up the Initiative remembered:
The decision to focus on tobacco came entirely from the data… We were looking
for an area related to a very large number of deaths worldwide… So, we looked at
the numbers and analysed them. They showed that smoking was now the world’s
leading single cause of death with over six million deaths per year compared with
three for AIDS, two for tuberculosis, one for malaria…We knew our focus had to be
tobacco.
Bill Gates was convinced by the numbers. He has a very mathematical mind. He just
read all the information. He read the Global Burden of Disease. He read the Tobacco
Atlas… And he did the maths. He saw the number of lives that can be saved. That is
why he became interested in tobacco and teamed up with Bloomberg.
Another good example of this belief that efforts to save lives need to be based on rigorous
data to be effective is the importance that the Initiative attaches to epidemiological
surveillance. As already mentioned, the Initiative has its own surveillance system: the Global
Adult Tobacco Survey (GATS), which is run by the CDC in collaboration with the WHO
and national health ministries and statistical agencies. Unlike its predecessor, the GYTS,
which is a school-based survey of 13–15 year olds, the GATS is a household survey of adults
that monitors tobacco use and key tobacco control indicators like public attitudes towards
smoking (CDC, 2009). For the experts at Bloomberg and Gates, this surveillance system is
deemed critical to the effective management of the Initiative and to determining whether it is
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achieving its goal to reduce ‘‘global adult smoking prevalence’’ below ‘‘20 per cent by 2020’’
(Frieden and Bloomberg, 2007, p. 1761). As one of them argued:
On-going, systematic surveillance is a key public health tool. It guides programme
implementation. It makes it possible to monitor results and evaluate whether
interventions are effective … Surveillance provides critical information … Who
smokes? Where? How much? Who is doing what in terms of policy?… If you cannot
measure it, you cannot manage it.
Within the epidemiological thought style at work throughout the Initiative, the notion of
epidemiological data is closely associated with a very specific quantification practice: social
surveys that focus on unhealthy lifestyles like smoking. This is evident when looking at the
epidemiological research and surveillance projects that inform the Bloomberg Initiative,
from the Global Burden of Disease venture and Peto’s studies on global smoking-
attributable mortality to the American Cancer Society’s NATIONS project and the CDC’s
GYTS and GATS. First, all these projects are concerned with quantifying the diverse
dimensions of tobacco use. For example, the Global Burden of Disease venture and the
research done by Peto and his colleagues both aim to measure tobacco consumption and its
impact on disease, disability and death (Peto et al., 1994; Murray and Lopez, 1996; Ng
et al., 2014). Similarly, the NATIONS, GYTS and GATS systems seek to quantify some of
the behavioural, economic, social and political aspects of smoking, including tobacco
consumption and second-hand smoke exposure; the production, trade and price of
cigarettes; people’s beliefs about tobacco; and the number of anti-smoking laws adopted
(Shafey et al., 2003; Warren et al., 2009). Second, all these projects also use one or another
type of social survey. So, the GYTS and GATS are, respectively, built around standardised
school-based and household surveys carried out by the CDC and its partners (Warren et al.,
2009). Similarly, Peto and his colleagues’ work is built around a few large observational
studies, which they conducted in the USA, India and China and for which they interviewed
people about their smoking habits and medical history (WHO, 1990; Peto et al., 1994; Liu
et al., 1998). Last but not least, the NATIONS system and the Global Burden of Disease
project operate by collecting and integrating surveys that have already been conducted by
other agencies, like the Demographic and Health Surveys funded by USAID and the
morbidity surveys carried out by community-based hospitals (Shafey et al., 2003; Smith,
2015).
Data within epidemiological reason is also – both in terms of its production and use –
closely associated with experts in epidemiology and the specialised public health institutions
in which they train and work. There is a myriad of such experts and institutions involved in
the Initiative. To start with, many epidemiologists and other public health specialists with
close links to the CDC – America’s premier federal public health agency – hold or have held
high-level positions within the Bloomberg and Gates foundations that involve commission-
ing, consulting and drawing upon epidemiological data to set up and/or manage the
Initiative. Tom Frieden and Kelly Henning are cases in point. Frieden, who played a critical
role in designing the Initiative, is a medical doctor and former CDC Epidemiological
Intelligence Service Officer. Similarly, Henning, the Director of International Health
Programmes at Bloomberg Philanthropies and, as such, the head of the Initiative, is a
physician trained in epidemiology at the CDC. David Fleming and Kathy Cahill, who
A genealogy of epidemiological reason
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together devised and managed the Gates Foundation’s tobacco control strategy, are another
two good examples. Fleming, also a physician by training, worked as Oregon’s State
Epidemiologist and CDC’s Deputy Director of Public Health Science before joining the Gates
Foundation. Likewise, Cahill trained in public health and was CDC’s Director for Planning,
Policy and Evaluation before being hired by the Gates Foundation. Furthermore, there are
also many epidemiologists working for public health schools or government health agencies
who, while not directly employed by the Initiative, make critical contributions to its operation
by providing the epidemiological data it needs. So, for example, Samira Asma and her group
of researchers at the CDC have been mandated by the Bloomberg and Gates foundations to
manage the GATS. In the same way, Gates funds Chris Murray, Alan Lopez and their team of
epidemiologists at the Institute of Health Metrics and Evaluation (IHME), University of
Washington, to run the Global Burden of Disease project (Smith, 2015). A further example is
Oxford epidemiologist Richard Peto who, together with colleagues like Prakash Gupta in
Mumbai and Bo-Qi Liu in Beijing, has produced much of the global smoking-
attributable mortality data on which the Initiative is based (WHO, 1990; Liu et al., 1998).
Last but not least, the epidemiological logic at work within the Initiative is also
characterised by a focus on the global and the notion of global population. In official
documents and reports, the Initiative is repeatedly depicted as a global effort to address a
worldwide threat. So, for example, in his writings, Frieden describes the joint Bloomberg–
Gates anti-smoking efforts as a ‘‘global initiative’’ to combat ‘‘the world’s leading
preventable epidemic’’ (Frieden, 2007, slide 24; Frieden and Bloomberg, 2007, p. 1761). In
the same way, the Gates Foundation (2009, 2015) explains that the Initiative is an
international ‘‘effort to combat the global tobacco epidemic’’ and ‘‘achieve a smoke-free
world’’. The assertion that tobacco use is a global threat is based on the epidemiological
research and surveillance projects discussed above. Indeed, the aim of these projects is to
quantify tobacco use and its burden for what is termed ‘‘the global population’’ (Lopez et al.,
2006, p. 8; CDC, 2015, p. 32). To illustrate, the aim of the GYTS and GATS is, according to
the CDC, to ‘‘monitor worldwide tobacco use’’ (Warren et al., 2009, p. 7). Likewise, Lopez
and his colleagues describe the goal of the Global Burden of Disease as being the
‘‘quantification of the impact of diseases, injuries and risk factors on the population health
globally’’ (Lopez et al., 2006, p. 5). To achieve that goal, these projects build on transnational
collaborations between public health schools, international organisations, philanthropies,
charities and government agencies to run social surveys across the globe and, where data is
inexistent, generate estimates using sophisticated modelling practices (Peto et al., 1994;
Smith, 2015). Much of the data from these projects comes in the form of metrics that seek to
capture every aspect of global tobacco use, from the ‘‘global adult smoking prevalence’’ to the
‘‘worldwide mortality from tobacco’’ (Peto and Lopez, 2000, p. 4; Frieden and Bloomberg,
2007, p. 1761). An extract from the Tobacco Atlas offers a striking example:
Almost 1 billion men in the world smoke … Almost 250 million women in the world
are daily smokers … Over 15 billion cigarettes are smoked worldwide everyday …
[There are] 4.2 million premature deaths from tobacco worldwide… Over five trillion
cigarettes are manufactured [globally] (Mackay and Eriksen, 2002, pp. 24–48).
Often, these metrics are further broken down by geo-political region or country and
displayed in tables and world maps (e.g., Mackay and Eriksen, 2002; Lopez et al., 2006;
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CDC, 2015). As experts working for the Initiative explain, these metrics, tables and maps
‘‘help us see the epidemic in its global scale’’ and ‘‘sell the need for worldwide tobacco
control’’ (Warren et al., 2009, p. 7).
A Genealogy
In contrast to much of the scholarly work on quantification in global health, my aim here is
not to celebrate the power of epidemiological reason or expose its shortcomings. Instead, my
concern is to understand how this thought style has come into being. Put differently, my
objective is to chart the way in which the central tenets of epidemiological reason – the will
to save lives, the belief in the importance of data, social surveys, epidemiologists and global
population – were articulated and assembled over time. Specifically, I explore below three
epistemological breaks that, I suggest, were critical in the making of this thought style: the
reconfiguration of political power around the idea of population in the long eighteenth and
nineteenth centuries; the shift from pathological anatomy to surveillance medicine in the
twentieth century; and the passage from international to global health at the start of the
twenty-first century.1 To espouse such a line of inquiry is to build on Hacking’s (2002)
historical ontology and, in particular, on his and others’ research on the making of statistical
reason (e.g., Hacking, 1990, 1992; Porter, 1995; Desrosie`res, 1998). Put simply, historical
ontology is a kind of genealogy in the sense Michel Foucault gave to the expression
(Hacking, 2002, chapter 1). In other words, it is a form of critique that, eschewing both
celebration and denunciation, seeks to unsettle the ‘‘feeling of inevitability’’ we attach to
many of the ‘‘things, classifications, ideas, kinds of people and institutions’’ that make up our
current ways of being and thinking (Hacking, 2002, pp. 5, 21). To do so, it ‘‘emphases the
contingency of the predicaments we find pressing or inescapable’’ today by tracing the
‘‘specific, local historical ways’’ and ‘‘epistemological ruptures’’ that have made them possible
(Hacking, 2002, pp. 3, 24, 93).2
Faith in Numbers and the Biopolitics of Population
Some key aspects of epidemiological reason can be traced back to the rupture in political
thought that took place in Europe and North America towards the end of the early modern
period. As Foucault (1998, 2009, 2014) argued, the West experienced at the time a
significant reformulation of the mechanisms of power around the new notion of population.
In the medieval tradition, a good government was part of the natural ‘‘world order willed by
1 The long eighteenth century – generally understood to last from the Restoration in 1660 or the Glorious
Revolution of 1688 to the Battle of Waterloo in 1815 or the Reform Act of 1832 – is an expression coined
by British and other historians to capture and analyse long-term historical developments that go beyond
the more standard calendar-based definition of the eighteenth century.
2 As Etienne Balibar (1978) has shown, the notion of ‘epistemological rupture’ can be traced back to the
work of French philosopher of science Gaston Bachelard. The notion was later taken up and reworked by
the French Marxist thinker Louis Althusser and both Georges Canguilhem and Michel Foucault before
being adopted by Ian Hacking.
A genealogy of epidemiological reason
 2017 Macmillan Publishers Ltd. 1745-8552 BioSocieties
God’’ (Foucault, 2009, p. 349). As a consequence, ‘‘the art of government’’ in the Middle-
Ages was about ‘‘knowing the positive laws of the country, the natural laws imposed on all
men and, of course, the laws and commandments of God’’ (Foucault, 2009, p. 273). As
societies in Europe and North America modernised, there was a radical departure from this
old cosmological–theological framework. An initial break was made in theories of raison
d’Etat and mercantilist philosophies that dominated political thought in the long eighteenth
century (Lemke, 2010). The art of government, according to these theories and philosophies,
was not about ‘‘the cosmos, nature or the divine’’ anymore but about ‘‘the preservation,
expansion and felicity of the state’’ (Foucault, 2009, p. 257). It is as part of this new
understanding of government that the notion of population, viewed as a measure of the
state’s power where strong states have large populations, was first sketched. A further break
from the medieval tradition was made in political economy, a body of thought that become
influential from the mid-1700s onwards (Lemke, 2010). For political economists, the
population was the final end and object of government, rather than simply an indicator of
the state’s power. Government, according to them, was about improving the condition of the
population understood as ‘‘an ensemble of individuals having between themselves relations
of coexistence and constituting therefore a specific reality’’ (Foucault, 2014, p. 117).
A crucial aspect of this new form of power was the way it redefined the relationship
between government and life. In the medieval tradition, this relationship was characterised
by ‘deduction’: the sovereign had a right to dispose of the lives of its subjects in the same way
it had a right to seize their goods and services (Foucault, 1998, p. 136). In contrast, the
relationship, in mercantilist and political economic philosophies, was marked by a will to
secure, foster and augment life. Indeed, for these theories, the population was not only a
political and economic reality but also a biological one. Therefore, in order to improve the
condition of the population, tending to the body politic and economic was not sufficient; it
was also critical to attend to the species body. For Foucault (1998, pp. 139–143), the
recognition of the ‘‘biological existence of a population’’ and the will to augment it through
what he called a ‘‘biopolitics of population’’ was the hallmark of ‘modernity’ and has
characterised modern Western societies up to this day (Lemke, 2010). In the long eighteenth
and nineteenth centuries, biopolitical efforts to secure and augment the life of the population
took the form of public hygiene and sanitation (Desrosie`res, 1998). For the most part, public
hygiene and sanitation was concerned with the deleterious urban environment brought
about by industrialisation and advocated public health policies that drew on anticonta-
gionist theories of miasma, such as sewers, waste collection and the ventilation of houses.
Modern biopolitical efforts to foster life came together with the development of new
quantification practices to measure the birth, marriage and death rates – or vital statistics –
of populations (Szreter, 1991; Desrosie`res, 1998). These practices, whose articulation in
nineteenth-century Europe and North America represented a significant moment in the
history of statistical reasoning, were centred around two specific techniques: (1) vital
registration systems to record births, marriages and deaths and (2) censuses to enumerate
each individual in the population. Administered by public health reformers with an interest
in statistics like Englishman William Farr and newly established national statistics agencies
like the UK’s General Register Office (GRO), these techniques involved national networks of
civil registry offices, standardised death certificates, electric cross-tabulation machines and
causes-of-death classifications (Szreter, 1991; Desrosie`res, 1998). In a modern regime of
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power, the knowledge about the population’s vital statistics generated through these
practices was deemed essential to a good politics of health. Indeed, in contrast to the
medieval tradition, where the prince governed in accordance to a natural or divine order, the
modern art of government was based on truth and, especially, scientific truth (Foucault,
2009, pp. 350–351). Moreover, the growing role of quantitative expertise and trust in
numbers in the government of public life during this period meant that more often than not
scientific truth was numerical (Hacking, 1990; Porter, 1995). It is therefore unsurprising that
the birth and death rates calculated by the new experts in vital statistics were quickly deemed
essential in guiding public hygiene and sanitation policies. A good example is the way in
which the statistics computed by the GRO under William Farr were received and used in the
UK during the nineteenth century (Szreter, 1991). Through its regular statistical bulletins,
the GRO did more than just provide authoritative information on death rates. It also actively
campaigned for districts throughout the country to adopt environmentalist public health
policies by raising awareness about the amount of preventable deaths and setting
acceptable death rate targets for local authorities to achieve.
What is important to note in relation to the genealogy mapped out here is that, at the start
of the twentieth century, a couple of key tenets of the epidemiological thought style at work
throughout the Bloomberg Initiative were in place in most nation-states across Europe and
North America. First, the desire to save and improve the greatest number of human lives that
informs the Initiative is a consequence of the reconfiguration of political thought around
population and the transformation of the relationship between power and life at the end of
the early modern period. Specifically, this desire grows out of the recognition of the
biological dimension of human existence and the will to augment it through a biopolitics of
population first expressed in mercantilist and political economic theories and characteristic
of most modern Western societies ever since (Foucault, 1998). Second, the belief held by
experts working for the Initiative that rigorous epidemiological data is critical for
safeguarding human lives effectively is the result of the history of statistical reasoning and
the central role that scientific knowledge and numbers came to play in regimes of power in
the modern era (Hacking, 1990; Porter, 1995). Precisely, this belief follows directly from the
view, embodied in the work of William Farr and the GRO in nineteenth-century UK, that
knowing the population’s vital statistics was essential to good public hygiene and sanitation
policies (Desrosie`res, 1998).
But, while these two central features of epidemiological reason were in place by the early
twentieth century, many other key tenets remained absent. One of these was the
quantification practices centred on the social survey and concerned with measuring the
many dimensions of tobacco use. As mentioned, the rupture in political thought at the end of
the early modern period had seen the development of another kind of quantification
practices, which were built around vital registration systems and geared to calculate the
population’s birth and death rates. While these vital statistics systems set up during the
nineteenth century shared some institutional and technical features with the survey-centred
quantification practices characteristic of the Bloomberg Initiative, their aim was very
different. Indeed, they purported to measure the effects of the environment – and, in
particular, the insalubrious urban milieu of mass industrialisation – on human life by
counting the number of deaths. They did not conceptualise and could not measure an
unhealthy individual behaviour like smoking and its various biological, social, political and
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economic dimensions. To quantify tobacco use in the way epidemiologists associated with
the Bloomberg Initiative do today, one would have to wait for the emergence of surveillance
medicine and the development of the social survey in the mid-twentieth century. Another
important feature of epidemiological reason that was also absent in the early 1900s is the
idea of a global population. It is true that, as we discussed above, the notion of population
was articulated as early as the 1700s and 1800s by mercantilists and political economists
(Foucault, 2009). But theirs was a national population, not a global one. It was the
population of the nation-state that was being articulated in Europe and America from the
late eighteenth century onwards (Anderson, 1983). As we will see, the idea of a global
population would only emerge in the late twentieth century as part of the shift from
international to global health.
Modern epidemiology and the social survey
As Armstrong (1983, 1995; cf. also Weisz, 2014) has argued, the mid-twentieth century saw
a rupture in medical thinking, with the emergence of surveillance medicine and the
displacement of pathological anatomy. A critical aspect of this rupture was a shift in the
medical gaze from the ‘pathological lesion’ located in the diseased body of the patient to the
‘risk factors’ of possible future diseases for everyone in the community, both the ill and the
seemingly healthy. The notion of risk factor was a product of actuarial studies in the life
insurance industry and research on child hygiene in the early twentieth century (Rothstein,
2003; Armstrong, 2009). Its rise to pre-eminence was also associated with a concomitant
change in North American and European disease patterns, which saw infectious diseases
drop while chronic conditions like coronary heart disease and lung cancer increased
markedly and began to be framed as a medical issue rather than the endpoint of natural
ageing (Armstrong, 2014). The new focus on risk factors had two consequences for medical
thought. First, the concern with future disease potential rather than actually existing diseases
led to the ‘‘dissolution of the clinical categories of healthy and ill’’ and a ‘‘problematisation of
the normal’’ (Armstrong, 1995, p. 395). Second, with the search for causes of future illness
now stretching from physiological attributes (e.g., blood pressure, weight) to behavioural
patterns or lifestyles (e.g., diet, smoking), medical thought was pushed beyond the body of
pathological anatomy and into an increasingly ‘‘extracorporeal space’’ (ibid, p. 401).
This shift in medicine’s gaze came together with changes to both its modes of knowing and
its forms of care. While the pathological lesion was investigated through clinical
examinations, laboratory tests and post-mortems with the ambition of discovering specific,
biological causal mechanisms, risk factors were charted through social surveys with the
aspiration of establishing statistical correlations (Brandt, 1990; Armstrong, 1995). The
investigative techniques and theories of causality associated with research on risk factors
were the products of modern epidemiology. Up to the 1920s, epidemiologists had been
physicians with no specific training often working as public health officers in government.
Their main duty was to investigate the sanitary conditions that caused infectious disease
outbreaks, using field investigations and laboratory tests (Amsterdamska, 2005). This
changed after the 1930s. Universities and medical schools set up chairs and degrees in
epidemiology, with the latter developing into a recognised, modern academic discipline
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weaving together elements from statistics, medicine and sociology and informed by the
ideals of welfarism (Armstrong, 1983; Susser and Stein, 2009). For the experts in this new
academic discipline, the task was to survey and alter the ‘‘harmful ways of living’’ that were
responsible for the mounting ‘‘modern epidemic’’ of chronic diseases (Morris, 1955, pp. 396
and 401; cf. also Oppenheimer, 2006). As with modes of knowing, the rupture in medical
thought also brought about the reconfiguration of forms of care. While treatment in
pathological anatomy was limited to the bodies of the sick in hospital beds, care in
surveillance medicine was ambulatory and on-going and delivered through community
health centres. It also assumed responsible patients who would actively engage in their
education and treatment, which comprised health promotion campaigns, screening tests and
life-long drug regimens (Armstrong, 1995; Petersen and Lupton, 2000). This shift in forms
of care was closely related to both the postwar articulation of the welfare state and its
politics of social solidarity and the concurrent development of a ‘new’ public health that,
unlike the ‘old’ public hygiene and its focus on the environment, was concerned with
lifestyles (Armstrong, 1983).
Importantly for us, the rise of surveillance medicine brought a change in how the life of the
population was conceived and quantified. Specifically, there was a move from the old vital
statistics machinery, which calculated the impact of insalubrious environments on human
mortality, to the new technique of the social survey, which measured the biological, social,
economic and political aspects of unhealthy lifestyles (Armstrong, 1983; Brandt, 1990;
Oppenheimer, 2006). As mentioned, the social survey grew out of the matrix of modern
epidemiology in the mid-twentieth century. The experts in this new academic discipline
developed and used two major types of survey in particular. The first was the morbidity or
health survey (Weisz, 2014). Carried out by health authorities to guide the provision of
healthcare, this type of survey collects information about the population’s health status and
behaviours as well as its healthcare access, utilisation and expenditure. It does so through
sociological analyses of people’s attitudes and experiences of disease like health profile
questionnaires and subjective health indexes, sometimes augmented by laboratory and
clinical examinations. A good example is the US National Health Interview Survey (NHIS) –
an interview-based household survey about the diseases, disabilities, lifestyles, hospital visits
and healthcare expenditure among Americans, carried out regularly by the US National
Centre for Health Statistics (NCHS) since the late 1950s (CDC, 2010). The second type of
survey was the observational study (Oppenheimer, 2006; Susser and Stein, 2009). Run by
epidemiologists working in universities and medical schools, this type of survey aims to
measure the impact of possible risk factors on the development of a given chronic disease,
using sociological and clinical examinations in combination with statistical techniques like
multivariate analysis and control groups. A well-known illustration is the research carried
out by Jerry Morris at the London School of Hygiene and Tropical Medicine (LSHTM) in
the 1950s. Drawing on a mix of direct observations, interviews, clinical examinations and
autopsies, Morris showed how physical inactivity was a key risk factor for cardiovascular
disease by comparing London bus drivers, who sat behind their wheel all day and had a high
risk of heart attacks, with bus conductors, who walked up and down the bus checking tickets
and rarely suffered heart attacks (Weisz, 2014).
Interestingly, smoking features centrally in the story of modern epidemiology and the
social survey (Brandt, 1990). To begin with, research on the causes of lung cancer and,
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particularly, the work of British statistician Austin Bradford Hill and physician Richard Doll
at the LSHTM was critical in developing the observational study as a recognised research
design. Hill, Doll and the LSHTM embodied the mixture of statistical, medical and
sociological expertise and the ideals of welfarism and social solidarity that were so typical of
modern epidemiology, with Doll in particular exhibiting a strong social conscience that led
him to join the Socialist Medical Association and advocate for the British National Health
Service (Armstrong, 1983; Weisz, 2014). Alerted by the growing mortality statistics for lung
cancer computed by the GRO, Hill and Doll ran two of the first, large population studies to
determine the risk factors associated with lung cancer: a case–control study comparing
patients suffering from lung cancer with patients having other diseases using interviews with
patients, analyses of medical records and autopsies; and, later, a cohort study comparing
smoking and non-smoking British doctors using questionnaires and death certificates (Doll
and Hill, 1950, 1954). In addition to demonstrating that lung cancer was caused by
individual behaviours like smoking rather than, as it was then thought, environmental
factors like pollution, their studies also pioneered a research design that would become the
‘‘paradigm for modern epidemiology’’ (Boyle, 2005). Moreover, as a direct consequence of
the work of Hill and Doll, questions about smoking became increasingly prominent in health
surveys. The USA, where an increasing number of nation-wide social surveys on smoking-
related behaviours were carried out from the 1960s onwards, provides a good illustration
(CDC, 2014). At first, questions about cigarette use, age of initiation and brand preference
were integrated into general health surveys like the NHIS mentioned above. Later, smoking
became one of the main subjects for interview-based surveys focusing on health-related risk
behaviours like the Behavioural Risk Factors Surveillance System (BRFS) run by the CDC.
More recently, one has seen the development of interview-based surveys focusing solely on
smoking, like the CDC’s National Youth Tobacco Survey (NYTS) and National Adult
Tobacco Survey (NATS), which explore topics like tobacco use and attitudes to smoking
(CDC, 2014).
Again, what is critical here is how the mid-twentieth-century advent of surveillance
medicine set in place a further two key features of contemporary epidemiological reason.
The first of these features are the experts in epidemiology and specialised public health
institutions that, because of their ability to produce, interpret and use data, are so critical to
the management of the Bloomberg Initiative. These experts and institutions have been made
possible by the development of a modern science of epidemiology concerned with chronic
diseases and lifestyles that accompanied the rise of surveillance medicine. Indeed, most
epidemiological experts who have influenced the Initiative, from Tom Frieden to Chris
Murray, have been trained in the new discipline of public health and epidemiology
developed by socially concerned physicians, statisticians and social scientists in universities
and medical schools after the 1930s. Richard Peto, whose research on global, smoking-
related mortality has been so influential for the Bloomberg Initiative, is probably the best
example. Trained in natural science and statistics, he turned to epidemiology after working
closely with Richard Doll, the physician and committed socialist who helped establish the
link between tobacco and lung cancer and pioneered observational studies. Similarly, almost
all the public health institutions which have been involved with Gates’ and Bloomberg’s anti-
smoking efforts, from the CDC and the American Cancer Society to the IHME and the Johns
Hopkins School of Public Health, follow and apply the ideas and techniques of modern
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epidemiology. The CDC offers a good illustration. Formed after World War Two to fight
malaria and other infectious diseases, it was comprehensively restructured under William
Foege in the late 1970s to address unhealthy lifestyles and chronic diseases and has since
become America’s premier public health agency (Etheridge, 1992).
The second key feature of epidemiological reason to grow out of surveillance medicine is
the social survey. The centrality of this quantification practice within the Bloomberg
Initiative was made possible by the development of modern epidemiology and the shift from
vital statistics and their interest in the environment to the social survey and its concern with
lifestyles. To start with, this shift in how the life of populations was conceived and measured
enabled the research and surveillance projects closely associated with the Initiative, from the
CDC’s GATS to the IHME’s Global Burden of Disease, to focus on a behavioural risk factor
like smoking. Furthermore, it also gave those projects the research design, be it in the form of
the health survey or the observational study, to quantify the different aspects of this
behaviour, from tobacco consumption and the disability and death burden it generated to
people’s attitudes towards smoking, the trade and price of cigarettes and the policy
landscape. A good example is Peto and his colleagues’ work on global, smoking-related
mortality. The large observational studies in the USA, China and India that have been at the
heart of this work were closely modelled on the two UK-based case–control and cohort
studies on lung cancer and smoking pioneered by Hill and Doll (WHO, 1990; Peto et al.,
1994; Liu et al., 1998). Another good example is the CDC’s GYTS and GATS. These surveys
were modelled on the NYTS and NATS already carried out by the Atlanta-based
organisation and, more generally, drew on the methods and infrastructures developed by
the CDC while running most North American health-related behaviour surveys over the last
40 years (CDC, 2014).
Globalisation, health and population
Most features of present-day epidemiological reason were in place by the end of the
twentieth century. One key aspect that was still missing was the notion of global population.
As mentioned earlier, the notion of population articulated by eighteenth- and nineteenth-
century mercantilists and political economists was a national one associated with the idea of
the nation-state that began to dominate political thought during the 1800s (Anderson, 1983;
Foucault, 2009). It was this concept of national population that permeated both nineteenth-
century vital statistics and twentieth-century social surveys and shaped their efforts to
measure the life of the nation (Armstrong, 1983; Desrosie`res, 1998). As we show below, the
idea of global population that characterises contemporary epidemiological reason only
emerged with the re-organisation of world health around the concept of globalisation at the
turn of the twenty-first century.
The post-Cold War period saw a rupture in the government of world health, with a
gradual shift from international to global health (Brown et al., 2006; Gaudillie`re, 2014). In
the international health model, which became predominant after the mid-1800s, nation-
states were the locus of biopolitical power and the prime agents for securing health (Weir
and Mykhalovskiy, 2010; Rees, 2014). They exercised absolute power on their territories
and worked together to address issues arising between them through international
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coordination mechanisms like the WHO and other United Nations agencies. Of course,
international health was, at first, a European and American affair, with the colonial
territories of Asia, Africa and the Caribbean governed through Empire and colonial
medicine. This changed with the end of Empire and the rise of International Development
after World War II, when the ex-colonies become members of the community of nation-
states, albeit immature ones in need of assistance from more advanced members. It is this
international health model that was eclipsed by the emergence of global health in the early
1990s. At the time, many policy and health experts thought that the world was undergoing
important changes (Reubi, 2016). Influenced by theories on globalisation, they believed that
trade liberalisation together with a revolution in transport and telecommunications was
erasing political and geographical boundaries. This, they feared, brought about new
transnational health threats – the rapid propagation of infections via air travel; the spread of
unhealthy lifestyles like smoking by multinationals – against which the international health
paradigm centred on the nation-state was of little help. For these experts, this inability of the
nation-state to deal with these threats was compounded by the wider, neoliberal critique of
the state as incompetent and wasteful (Mirowski and Plehwe, 2009). The global health
model of government was a response to these perceived weaknesses. It has encouraged new
forms of transnational action that redistribute biopolitical power to non-state actors and
erode the sovereignty of nation-states. These include international treaties vesting organ-
isations with supra-national powers, as with the 2005 International Health Regulations
giving the WHO the right to unilaterally declare public health emergencies (Weir and
Mykhalovskiy, 2010). They also involve transnational partnerships between philanthropies,
civil society groups, private corporations and governments like the Global Alliance for
Vaccines and Immunisation and the Global Fund to Fight AIDS, Tuberculosis and Malaria
set up at the start of the new millennium (Rees, 2014).
This shift from international to global health is particularly evident in the organisation
and management of worldwide anti-smoking efforts. Up to the 1990s, these efforts were
organised around the nation-state and international development (Reubi and Berridge,
2016). The International Union against Cancer’s influential Smoking and Cancer Pro-
gramme, which ran from the mid-1970s to the early 1990s, is a case in point. Its aim was to
build tobacco control capacity in developing countries by having North American and
European experts go and teach local policymakers, civil servants and doctors how to set up
national anti-smoking agencies and draw up national tobacco control policies. This changed
at the turn of the twenty-first century, when anti-smoking efforts began to build on the idea
of globalisation and forms of action involving non-state actors (Reubi and Berridge, 2016).
The FCTC, whose making formed a key part of Gro Harlem Brundtland’s attempts to
revitalise the WHO under the banner of global health, is a great example (Brown et al.,
2006). To start with, Brundtland and her allies explicitly framed the FCTC as the answer to
smoking understood as a global threat – a ‘‘globalisation of unhealthy lifestyles’’ caused by a
‘‘globalisation of trade and marketing’’ – against which individual nation-states were
powerless (Brundtland, 2000, p. 51). Furthermore, the adoption of the FCTC was made
possible by the efforts of a pioneering transnational coalition of civil society organisations
(Reubi and Berridge, 2016). Another example is the Bloomberg Initiative itself. Like the
FCTC, the Initiative is being officially framed as a global solution – ‘‘broadening and
accelerating the global tobacco control movement’’ – to a global threat – ‘‘the global tobacco
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epidemic’’ (Bloomberg Philanthropies, 2011, p. 11; Gates, 2015). Furthermore, the idea of
partnership between state and non-state actors is at the heart of the Initiative. This is
manifest in the type of organisations – the Bloomberg and Gates foundations, the WHO, the
CDC, health charities, public health schools, health ministries and local NGOs – that make
up and work for the Initiative. It is also evident in the Bloomberg and Gates foundations’
policy documents, which stress the need for ‘‘partnerships’’ with ‘‘government, philanthropy
and business’’ as well as ‘‘communities and individuals’’ from ‘‘around the world’’
(Bloomberg Philanthropies, 2015, p. 5; Gates, 2016).
The shift from international to global health was associated with changes in world health
metrics, both in terms of the type of actors involved and how they associated and in terms of
the sort of numbers being produced. Within the international health paradigm, nation-states
had the sovereign power to collect and publish health statistics about their national
population and, before decolonisation, the populations in their colonies (Weir and
Mykhalovskiy, 2010). As a result, the statistical reports prepared by international health
agencies like the WHO could only contain data that nation-states had computed and
published or otherwise released through official channels. This meant that most of these
reports did not include any global or regional numbers but only tabulated, country by
country, the national statistics that these states had formally released. It also meant that, in a
postcolonial world where few newly independent states had any statistical expertise, these
reports had no or no reliable data for many countries (Reubi, 2016; Smith, 2015). A good
example of this conception of health metrics is the pre-1983 editions of the WHO World
Health Statistics – an annual report that continued the League of Nations’ Annual
Epidemiological Reports and contained information about causes and number of deaths,
rates of infectious diseases and healthcare facilities.3 The information in these reports was
tabulated by country, with no single global or regional numbers. Furthermore, the data used
for the reports came exclusively from ‘‘official national statistics’’ ‘‘released by the competent
authorities of the countries concerned’’, such as ‘‘annual reports of national health
administrations’’ and ‘‘questionnaires filled in by the central statistics offices’’ (WHO, 1976a,
p. 5; 1976b, p. 4). Also, the reports covered very few developing countries, with, for
example, the 1976 edition including mortality data for only 2 African and 5 Asian countries,
half of which were considered to be of ‘‘poor quality’’ (WHO, 1976a, pp. 6–9). Interestingly,
while the World Health Statistics themselves did not contain regular data about tobacco
until 2005, the WHO’s earliest international statistics on smoking dating from the mid-
1980s followed a similar format. Thus, they listed the smoking prevalence for each Member
State without giving any global figure and the data for developing countries was considered,
by experts in the field, to be widely off the mark (WHO, 1985, Annex 1; Reubi, 2016).
This earlier conception of world health metrics began to change in the late twentieth
century, when new transnational epidemiological surveillance and research projects were
developed. These projects included most of the epidemiological studies that have been so
influential for the Bloomberg Initiative like the Global Burden of Disease venture, Peto’s
research on global smoking-attributable mortality and the CDC’s GYTS. They also included
3 The name of the WHO’s annual world statistical report has changed over time. It was entitled the Annual
Epidemiological and Vital Statistics up to 1964, when it was renamed the World Health Statistics Annual.
It kept this title until 1995 and, after a ten-year absence, came back as World Health Statistics.
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other studies like the WHO MONICA Project, which monitored cardiovascular diseases
across four continents, and the USAID Demographic and Health Surveys (DHS), which have
surveyed maternal and child health in over 80 countries (Tunstall-Pedoe, 2003; Corsi et al.,
2012). In keeping with the new global health paradigm and in contrast to the earlier
conception of world health metrics articulated around national authorities, these projects
were run by transnational coalitions of state and non-state actors: universities, philan-
thropies, charities, health ministries, aid agencies and inter-governmental organisations.
Likewise, far from being limited to official statistics, these projects drew on a variety of
sources (Weir and Mykhalovskiy, 2010). Some, like the DHS and the GYTS, conducted their
own surveys in a multiplicity of countries, something that was made possible by the erosion
of state sovereignty and the rise of affordable air travel. Others like the Global Burden of
Disease project built on innovations in information and communication technology to
collect, assess, recalibrate and integrate existing stores of health data from across the world
into complex statistical models (Smith, 2015). Moreover, unlike the national focus that
typified the earlier model of world health metrics, these new transnational projects were
‘‘worldwide monitoring systems’’ concerned with figures and trends that pertained to the
‘‘world population’’ (WHO, 1989, p. 27; Tunstall-Pedoe, 2003, p. 76). The WHO World
Health Statistics reports from 1983 onwards offer a good illustration of this shift in the
understanding of world health metrics. To start with and in contrast to earlier editions, the
figures contained in these reports were ‘‘computed by the WHO’’ and ‘‘not necessarily the
official statistics of Member States’’ (WHO, 2005, p. 13). Indeed, to compute these figures,
the WHO followed a complex process, collecting any available data ‘‘in addition to national
statistics’’ before assessing their quality, compiling them and estimating any missing element
(WHO, 2006, p. 7). Furthermore, while these reports continued to list national statistics for
each Member State, they now also offered a ‘‘global overview’’ of the ‘‘world health
situation’’ by deploying ‘‘global indicators’’ and world maps (WHO, 1983, p. 7; 1993, p. 19;
2005, p. 7). Importantly for us, smoking prevalence quickly became one of these global
indicators. Thus, in its 1986 report, the WHO included a section exploring the ‘‘worldwide
[smoking] trends’’ and, specifically, the ‘‘world consumption of cigarettes’’ (WHO, 1986,
pp. 16–18). It included a map of the world, with countries shaded in different colours
marking different consumption levels, and a graphic comparing cigarette consumption and
population numbers in the world and some of its geographical regions (WHO, 1986,
Figures 4 and 5). And, from 2005 onwards, the editions of World Health Statistics regularly
reported on smoking prevalence using the CDC’s GYTS data and giving numbers for the
globe, the WHO regions and each Member State (WHO, 2005).
To finish, it is worth noting the significant role played by philanthropies in the shift from
international to global health and the associated changes in world health statistics (Reubi,
2017). Of course, the involvement of philanthropies in world health and metrics is not new.
The Rockefeller Foundation, for example, sought to spread vital statistics to the mostly
British colonies of South-East Asia in the first half of the twentieth century, funding the
League of Nations’ weekly radio-telegraphic epidemiological bulletins drafted by its Far
Eastern Bureau in Singapore (Bashford, 2006). However, the recent shift to global health has
led to the re-emergence of philanthropies as major actors in world health (Rushton and
Williams, 2011). Indeed, as alluded to, policy and health experts have increasingly come to
view philanthropic foundations, usually in partnership with other non-state actors, as the
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answer to the perceived weaknesses of the international health model centred on the nation-
state. One area in which philanthropists active in world health have been particularly keen
to invest is the development of new global health metrics, with many of them funding
transnational surveillance systems and epidemiological research projects. Gates and
Bloomberg’s financial support of the IHME’s Global Burden of Disease project and the
CDC’s GATS – which are critical to contemporary epidemiological reason – are cases in
point. These philanthropists’ interest in metrics grows, at least in part, out of the practices of
audit that came to dominate the government of corporate and public life in the late twentieth
century (Power, 1999; Shore and Wright, 2015). Gates, for example, is usually regarded as
‘‘one of the high priests’’ of the new culture of audit ‘‘built around the massive gathering and
meticulous analysis of numerical data’’, with Microsoft managers expected to ‘‘crunch
numbers for everything before they make decisions’’ (Smith 2015, p. 148). Likewise,
Bloomberg has repeatedly stressed that his business philosophy was all about ‘‘following the
data’’, famously stating that: ‘‘In God we trust; everyone else bring data’’ (Bloomberg
Philanthropies, 2013, p. 3). It is a philosophy that he brought with him when he moved to
City Hall where, inspired by New Public Management ideals of transparency and
accountability, he set up multiple systems to monitor and assess the efficiency of New
York City’s public services (Brash, 2011). Given their commitment to data and audit
practices, it is perhaps no surprise that both Gates and Bloomberg saw the metrics and
surveillance systems developed by epidemiologists as the perfect tool to monitor and assess
their charitable efforts in global health. As Gates argued, ‘‘the metric of success [in global
health] is lives saved’: like ‘units sold’ and ‘profits achieved’, it is ‘all very measurable and
you can set ambitious goals and see how you do’’ (cited in Smith, 2015, p. 149). Bloomberg
held similar views, as one epidemiologist working for him recounted:
Bloomberg is 100 per cent about data. His entire business is built on data. At City Hall
he implemented all sorts of data-driven initiatives. This is a person very interested in
data. Similarly, I am a trained epidemiologist and my focus is also on data…We both
just want to know what impact we are having. That is why we fund measurement
strategies like the GATS.
Conclusion
Focusing on the Bloomberg Initiative, one of the largest international efforts to tackle the
NCD epidemic currently spreading across the global South, this article explored the ubiquity
and growing significance of numbers in the field of global health. In these concluding
remarks, I want to underline and discuss what, I believe, are two of the major insights that
this article can offer to other scholars in the social sciences and humanities who are
researching and writing about global health metrics.
The first of these insights is the notion of epidemiological reason, which builds on the idea
of thought style articulated by Hacking and others. Of course, the notion of epidemiological
reason which I introduced and outlined in the first part of this article stems exclusively from
my research on the Bloomberg Initiative. But, given that many of the forms of knowledge
and practices associated with global health are shared across the field, it is reasonable to
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assume that other global health initiatives are informed by styles of thinking which, to
borrow from Wittgenstein (2009, p. 36), have strong ‘‘family resemblances’’ to the notion of
epidemiological reason I explored here. In any case, this notion of epidemiological reason
draws our analytical gaze to the wider logic that knits together, organises and shapes the
metrics that saturate the field of global health. As I showed in the article, this logic combines
a multiplicity of different elements, from the ethical imperative to save lives and the expert
figure of the epidemiologist to the political category of the global and the social-scientific
technique of the survey. These different elements do not need to be entirely consistent with
each other. An excellent example is the way epidemiological reason brings together and
combines the technique of the social survey, which was developed by ardent proponents of
the welfare state like Doll, with committed capitalists like Bloomberg and Gates. The article
also highlighted the critical role that modern epidemiology plays in the making of
epidemiological reason as with the social survey or the figure of the epidemiologist and it is
to be expected that other, somewhat related bodies of knowledge which we did not have the
time and space to explore here like health economics and evidence-based medicine play a
similar role (Reubi, 2013; Adams, 2016a). Finally, while epidemiological reason might well
foreclose other ways of thinking and being, it is important to understand that it is also
central to the production of many of the ideas and objects that circulate within the
contemporary political and moral economy of global health – as when epidemiologists,
surveys and maps come together to turn smoking into today’s largest ‘global’
preventable epidemic.
The second insight is the history or historical ontology of global health metrics sketched in
the second part of the article. Drawing on a long tradition of genealogical studies, this
history emphasises the importance of ruptures and eschews the Whiggish tales of scientific
progress or neoliberal doom that can be found in parts of the literature. In particular, and
contrary to what some scholars have argued, the article showed that many key ideas and
practices associated with global health metrics like the desire to save lives and the trust in
numbers are not a recent phenomenon associated with neoliberal rule but the product of a
rupture in political thought at the end of the early modern era associated with the birth of
biopolitics and statistical thinking. This is why, as I illustrated, there are many important
similarities between the way William Farr and his allies used vital statistics to campaign for,
set targets and assess sanitation efforts in mid-nineteenth-century UK and the way Tom
Frieden and his colleagues have drawn on epidemiological data on smoking to devise and
manage the Bloomberg Initiative. It would, however, be a mistake to think that nothing has
changed since Farr and the development of vital statistics. Indeed, as the article also showed,
the very practices of quantification and the life being quantified have changed over time.
Specifically, the quantification practices that permeate the Bloomberg Initiative and other
global health efforts stem from the emergence of surveillance medicine and the concomitant
shift from vital statistics, with their concern for the impact of insalubrious environments on
human mortality, to the social survey, with its interest in the biological, social, economic and
political aspects of unhealthy lifestyles. Furthermore, the population whose life is quantified
together with the infrastructure supporting these quantification efforts has, they too,
changed since the time of Farr. In particular, the idea of a world population and the
involvement of transnational partnerships of state and non-state actors that characterise
efforts like the Bloomberg Initiative are the product of the twenty-first century re-
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organisation of world health around the idea of globalisation and a breakaway from the
notion of national population and the state-centric infrastructure typical of vital statistics.
In conclusion, I believe that these different insights show the tremendous value of
adopting a genealogical approach when seeking to make sense of the nuances and
complexities of the contemporary spirit of quantification. In our age of big data in which
numbers are so ubiquitous, this is not just the case for global health, which is the object of
the present article, but for most other spheres of political, economic and social life too.
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